There is no licensed vaccine for this disease. It has a fatality rate of up to 88%.
Sabin Vaccine Institute
Currently, there are no licensed vaccines or treatments for Marburg, which has a mortality rate of up to 88%. Sabin’s single-dose vaccine, based on the cAd3 platform, is in Phase 2 trials in Uganda and Kenya with no safety concerns reported to date.
University of Oxford
There are no approved treatments, but the University of Oxford have launched a new clinical trial to test a vaccine.
Symptoms of Marburg Virus
Severe Headaches
Aching joints
high fever
gastric disturbance